Status:
COMPLETED
Disease Management for Smoking Cessation
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
GlaxoSmithKline
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for smoking. The hypotheses are to compare abstinence from cigarettes, the numb...
Detailed Description
The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for nicotine dependence. In this study, we will recruit 750 smokers from 20 rur...
Eligibility Criteria
Inclusion
- Over the age of 18
- Reported smoking at least 10 cigarettes per day for at least 25 of the last 30 days
- Speak English
- Their regular physician is a participating physician
- Working home telephone or cellular phone
Exclusion
- Women who are pregnant or planning to become pregnant in the next two years
- Plan on moving within two years
- Display signs of dementia or other mental disorders
- Live with a smoker already enrolled
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00440115
Start Date
June 1 2009
End Date
December 1 2010
Last Update
June 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160